DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Pred-Mild (Prednisolone Acetate Ophthalmic) - Indications and Dosage

 
 



INDICATIONS AND USAGE

PRED MILD® is indicated for the treatment of mild to moderate noninfectious allergic and inflammatory disorders of the lid, conjunctiva, cornea, and sclera (including chemical and thermal burns).

DOSAGE AND ADMINISTRATION

Shake well before using. Instill one to two drops into the conjunctival sac two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased if necessary. Care should be taken not to discontinue therapy prematurely.

If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (see PRECAUTIONS).

HOW SUPPLIED

PRED MILD® (prednisolone acetate ophthalmic suspension, USP) 0.12% is supplied sterile in opaque white LDPE plastic bottles with droppers with white high impact polystyrene (HIPS) caps as follows:

5 mL in 10 mL bottle - NDC 11980-174-05
10 mL in 15 mL bottle - NDC 11980-174-10

Storage: Store at 15°-30°C (59°-86°F) in an upright position. Protect from freezing.

Revised: 04/2014

© 2014 Allergan, Inc.
Irvine, CA 92612, U.S.A.
® marks owned by Allergan, Inc.
Made in the U.S.A.

71739US11

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017